Reversible suppression of menstruation with progesterone antagonists in rhesus macaques

Ov Slayden, K. Chwalisz, R. M. Brenner

    Research output: Contribution to journalArticle

    43 Citations (Scopus)

    Abstract

    Background: A reliable means of menstrual suppression would greatly improve the quality of life for women. Information is lacking on the direct endometrial effects and appropriate dosages of new antiprogestins that may be useful for this purpose. Methods: The current work evaluated three different systems in macaque monkeys. First, the range of doses of two relatively new antiprogestins, ZK 137 316 and ZK 230 211, that would block progesterone action directly on the endometrium in artificially cycled, spayed rhesus macaques; second, the direct endometrial effects of ZK 230 211, a type III antiprogestin; and third, investigation of whether endometrial-suppressive doses administered chronically to intact, cycling monkeys could be used for reversible, menstrual suppression. Results: The results in naturally cycling animals showed that ZK 137 316 blocked menstruation in all animals, but doses of 0.05 mg/kg blocked ovulation in 55.5% of animals and doses of 0.1 mg/kg blocked ovulation in 66.6% of the animals. However, all doses of ZK 230 211 that blocked menstruation also blocked ovulation. All progesterone antagonist (PA)-treated animals, regardless of dose, maintained normal follicular phase concentrations of oestradiol and returned to normal menstrual cyclicity within 15-41 days post-treatment. Therefore ZK 137 316, depending on dose, can allow ovulation but block menstruation, while ZK 230 211, a much more potent PA, blocks both ovulation and menstruation at all effective doses. Both PAs block unopposed oestrogenic action on the endometrium through their antiproliferative effects. Conclusions: Reversible amenorrhoea can be achieved with these two PAs, and they can protect the endometrium from the effects of unopposed oestrogen whether or not ovulation is blocked. Chronic, low dose PA treatment may provide a new option for women who wish to suppress their menstrual periods.

    Original languageEnglish (US)
    Pages (from-to)1562-1574
    Number of pages13
    JournalHuman Reproduction
    Volume16
    Issue number8
    StatePublished - 2001

    Fingerprint

    Menstruation
    Ovulation
    Macaca mulatta
    Progesterone
    Endometrium
    Haplorhini
    Follicular Phase
    Amenorrhea
    Macaca
    Periodicity
    Estradiol
    Estrogens
    Quality of Life
    Therapeutics

    Keywords

    • Endometrium
    • Macaque
    • Menstruation
    • Ovulation
    • Progesterone antagonists

    ASJC Scopus subject areas

    • Physiology
    • Developmental Biology
    • Obstetrics and Gynecology
    • Reproductive Medicine

    Cite this

    Reversible suppression of menstruation with progesterone antagonists in rhesus macaques. / Slayden, Ov; Chwalisz, K.; Brenner, R. M.

    In: Human Reproduction, Vol. 16, No. 8, 2001, p. 1562-1574.

    Research output: Contribution to journalArticle

    Slayden, Ov ; Chwalisz, K. ; Brenner, R. M. / Reversible suppression of menstruation with progesterone antagonists in rhesus macaques. In: Human Reproduction. 2001 ; Vol. 16, No. 8. pp. 1562-1574.
    @article{c4ffad2c5ad64e47a12eefea39c4b48c,
    title = "Reversible suppression of menstruation with progesterone antagonists in rhesus macaques",
    abstract = "Background: A reliable means of menstrual suppression would greatly improve the quality of life for women. Information is lacking on the direct endometrial effects and appropriate dosages of new antiprogestins that may be useful for this purpose. Methods: The current work evaluated three different systems in macaque monkeys. First, the range of doses of two relatively new antiprogestins, ZK 137 316 and ZK 230 211, that would block progesterone action directly on the endometrium in artificially cycled, spayed rhesus macaques; second, the direct endometrial effects of ZK 230 211, a type III antiprogestin; and third, investigation of whether endometrial-suppressive doses administered chronically to intact, cycling monkeys could be used for reversible, menstrual suppression. Results: The results in naturally cycling animals showed that ZK 137 316 blocked menstruation in all animals, but doses of 0.05 mg/kg blocked ovulation in 55.5{\%} of animals and doses of 0.1 mg/kg blocked ovulation in 66.6{\%} of the animals. However, all doses of ZK 230 211 that blocked menstruation also blocked ovulation. All progesterone antagonist (PA)-treated animals, regardless of dose, maintained normal follicular phase concentrations of oestradiol and returned to normal menstrual cyclicity within 15-41 days post-treatment. Therefore ZK 137 316, depending on dose, can allow ovulation but block menstruation, while ZK 230 211, a much more potent PA, blocks both ovulation and menstruation at all effective doses. Both PAs block unopposed oestrogenic action on the endometrium through their antiproliferative effects. Conclusions: Reversible amenorrhoea can be achieved with these two PAs, and they can protect the endometrium from the effects of unopposed oestrogen whether or not ovulation is blocked. Chronic, low dose PA treatment may provide a new option for women who wish to suppress their menstrual periods.",
    keywords = "Endometrium, Macaque, Menstruation, Ovulation, Progesterone antagonists",
    author = "Ov Slayden and K. Chwalisz and Brenner, {R. M.}",
    year = "2001",
    language = "English (US)",
    volume = "16",
    pages = "1562--1574",
    journal = "Human Reproduction",
    issn = "0268-1161",
    publisher = "Oxford University Press",
    number = "8",

    }

    TY - JOUR

    T1 - Reversible suppression of menstruation with progesterone antagonists in rhesus macaques

    AU - Slayden, Ov

    AU - Chwalisz, K.

    AU - Brenner, R. M.

    PY - 2001

    Y1 - 2001

    N2 - Background: A reliable means of menstrual suppression would greatly improve the quality of life for women. Information is lacking on the direct endometrial effects and appropriate dosages of new antiprogestins that may be useful for this purpose. Methods: The current work evaluated three different systems in macaque monkeys. First, the range of doses of two relatively new antiprogestins, ZK 137 316 and ZK 230 211, that would block progesterone action directly on the endometrium in artificially cycled, spayed rhesus macaques; second, the direct endometrial effects of ZK 230 211, a type III antiprogestin; and third, investigation of whether endometrial-suppressive doses administered chronically to intact, cycling monkeys could be used for reversible, menstrual suppression. Results: The results in naturally cycling animals showed that ZK 137 316 blocked menstruation in all animals, but doses of 0.05 mg/kg blocked ovulation in 55.5% of animals and doses of 0.1 mg/kg blocked ovulation in 66.6% of the animals. However, all doses of ZK 230 211 that blocked menstruation also blocked ovulation. All progesterone antagonist (PA)-treated animals, regardless of dose, maintained normal follicular phase concentrations of oestradiol and returned to normal menstrual cyclicity within 15-41 days post-treatment. Therefore ZK 137 316, depending on dose, can allow ovulation but block menstruation, while ZK 230 211, a much more potent PA, blocks both ovulation and menstruation at all effective doses. Both PAs block unopposed oestrogenic action on the endometrium through their antiproliferative effects. Conclusions: Reversible amenorrhoea can be achieved with these two PAs, and they can protect the endometrium from the effects of unopposed oestrogen whether or not ovulation is blocked. Chronic, low dose PA treatment may provide a new option for women who wish to suppress their menstrual periods.

    AB - Background: A reliable means of menstrual suppression would greatly improve the quality of life for women. Information is lacking on the direct endometrial effects and appropriate dosages of new antiprogestins that may be useful for this purpose. Methods: The current work evaluated three different systems in macaque monkeys. First, the range of doses of two relatively new antiprogestins, ZK 137 316 and ZK 230 211, that would block progesterone action directly on the endometrium in artificially cycled, spayed rhesus macaques; second, the direct endometrial effects of ZK 230 211, a type III antiprogestin; and third, investigation of whether endometrial-suppressive doses administered chronically to intact, cycling monkeys could be used for reversible, menstrual suppression. Results: The results in naturally cycling animals showed that ZK 137 316 blocked menstruation in all animals, but doses of 0.05 mg/kg blocked ovulation in 55.5% of animals and doses of 0.1 mg/kg blocked ovulation in 66.6% of the animals. However, all doses of ZK 230 211 that blocked menstruation also blocked ovulation. All progesterone antagonist (PA)-treated animals, regardless of dose, maintained normal follicular phase concentrations of oestradiol and returned to normal menstrual cyclicity within 15-41 days post-treatment. Therefore ZK 137 316, depending on dose, can allow ovulation but block menstruation, while ZK 230 211, a much more potent PA, blocks both ovulation and menstruation at all effective doses. Both PAs block unopposed oestrogenic action on the endometrium through their antiproliferative effects. Conclusions: Reversible amenorrhoea can be achieved with these two PAs, and they can protect the endometrium from the effects of unopposed oestrogen whether or not ovulation is blocked. Chronic, low dose PA treatment may provide a new option for women who wish to suppress their menstrual periods.

    KW - Endometrium

    KW - Macaque

    KW - Menstruation

    KW - Ovulation

    KW - Progesterone antagonists

    UR - http://www.scopus.com/inward/record.url?scp=0034893862&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0034893862&partnerID=8YFLogxK

    M3 - Article

    C2 - 11473944

    AN - SCOPUS:0034893862

    VL - 16

    SP - 1562

    EP - 1574

    JO - Human Reproduction

    JF - Human Reproduction

    SN - 0268-1161

    IS - 8

    ER -